Microfluidic Technology for Cancer Diagnosis
Exploring some of the microfluidic technologies used for cancer diagnosis
Today’s Clinical Lab is a reader-centric publication that keeps clinical professionals up to date with today’s rapidly changing lab industry with in-depth and timely editorial content and resources, including clinical industry news and insights into the latest trends, technologies, and techniques in the clinical lab.
ViewFull ProfileLearn about ourEditorial Policies.
Early cancer diagnosis contributes to improved prognosis and overall survival. Achieving an early diagnosis with current diagnostic imaging techniques is challenging, as small tumors often fall below the detection threshold for imaging. Further, while solid tissue biopsy is considered a gold standard diagnostic method, it may be painful for patients, and tumor heterogeneity may contribute to inconclusive results. Liquid biopsy offers a minimally invasive alternative to current imaging and biopsy techniques, and may be combined with microfluidic platforms to detect circulating tumor cells for early diagnosis. Here we explore some of the microfluidic technologies used for cancer diagnosis.
Download the FREE infographic courtesy of Clinical Lab Manager.
